Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1 - Wikidata - wikimedia - TriplyDB

Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1

Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1

http://www.wikidata.org/entity/Q35060239

about

Maillard reaction products and potatoes: have the benefits been clearly assessed?Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled Trials Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management Food Processing and the Mediterranean Diet Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance Dietary advanced glycation end products and their role in health and disease Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals.The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment.Dietary Sugars and Endogenous Formation of Advanced Glycation Endproducts: Emerging Mechanisms of Disease.Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: meta-analysis of randomised controlled trials.Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components.A plant-based diet for the prevention and treatment of type 2 diabetes.AGEs induce ectopic endochondral ossification in intervertebral discs Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial Diet and Diabetic Kidney Disease: Plant Versus Animal Protein.Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.Potential health hazards of eating red meat.Advanced glycation end products in infant formulas do not contribute to insulin resistance associated with their consumption.Dietary fat quantity and quality modifies advanced glycation end products metabolism in patients with metabolic syndrome.A novel role for SIRT-1 in L-arginine protection against STZ induced myocardial fibrosis in rats.Chronic ingestion of advanced glycation end products induces degenerative spinal changes and hypertrophy in aging pre-diabetic mice.Accumulation of advanced glycation end-products and activation of the SCAP/SREBP Lipogenetic pathway occur in diet-induced obese mouse skeletal muscle Sirt1 deletion leads to enhanced inflammation and aggravates endotoxin-induced acute kidney injury Advanced glycation end products and oxidative stress in type 2 diabetes mellitus.Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?Association between Advanced Glycation End Products and Impaired Fasting Glucose: Results from the SALIA Study Development of Diagnostic Fragment Ion Library for Glycated Peptides of Human Serum Albumin: Targeted Quantification in Prediabetic, Diabetic, and Microalbuminuria Plasma by Parallel Reaction Monitoring, SWATH, and MSE Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients.Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial.Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift.Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children.AGE restriction in diabetes mellitus: a paradigm shift.Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients.

P2860

Q26752682-5FD6E6AF-D005-43CA-845D-F99DB2BBF755 Q26764769-5A29E9A9-1A43-40B9-A82F-FB06A7E003CC Q26781156-98064790-19C8-4D8C-8E84-B5A35AA20C24 Q26782234-9BDE0F7D-1983-47BF-B2B1-EA2FB397277D Q26800114-B28B6C27-828E-42CC-AAD3-B181BF2A39E5 Q26801247-D5AE82D3-060D-4640-8AF2-23667E857180 Q30575530-80E772A3-072B-4A84-A136-1D7279C4C349 Q33584606-54C9A080-F666-4B3F-802F-126B98C17906 Q33607272-870E96BF-AE30-40F2-AC28-5836AD3BDAC6 Q33616876-E9FAD777-05AB-4FAD-ACD2-CEBD815C0406 Q33720039-0902861D-4167-483D-8EDE-466C92DE9DD2 Q33742916-2B1416C2-AA12-4AB5-8582-55FAE39B16B7 Q33785577-992EB491-D11F-4065-B1D1-7C2E6CC1D4C2 Q33828356-CB84BCEF-93C4-4234-9AB0-F8A12451E1AC Q33829924-C71E9325-DA18-493D-84F0-1FB8706B6E56 Q33889472-BA813813-8A88-4756-9FBC-E40C023A4CC1 Q33904838-13213357-F8B1-4693-B9C9-74686DD48A0F Q34539490-F066F482-5AA0-48E5-B2CD-988603CB5502 Q34542291-C34F98B0-AC50-492F-A929-D2766ABCC305 Q34680886-ECCA70C4-5654-41B0-BFBE-0AF7DA8C3051 Q34689447-375854E9-2052-4964-9A0C-6C506DD4F6DE Q35068710-371E58CB-448A-4459-8EE0-81934F479B32 Q35159141-2ED15743-5AF8-41DD-B5DD-CCD4BAC2AFA6 Q35181466-EB611D0F-4451-482B-8C88-4A3DCA765D5E Q35255473-58A4BED9-4C9A-4B6B-9068-8B806B4B2FBF Q35576119-17DCBF63-B4A3-4EA8-BDDB-44F1E9872EF9 Q35578295-3B303C2E-06E6-4D89-B72C-70F62613F6AC Q35644178-B16E4C1C-CF8A-4991-A615-6A19A79C285C Q35645788-79D52107-A142-4340-9EF7-F7F043C38EDE Q35995060-B52BB2CC-B08B-45FD-A117-88F73B5EC574 Q36080001-8E33797F-A522-48DC-B5BC-8361BDAC0042 Q36081850-E1F9EBA7-0B0F-4509-8E58-F84E301A8BE7 Q36300685-761911DE-CB20-4A32-AC31-657980516D77 Q36458415-6F0DEDB1-DA86-46F5-ABBC-4CEF9F1124F3 Q36571129-8B528FFA-9446-470F-928A-B197E81CB97D Q36796216-63A9C790-67D0-40CE-8E29-C6E3D08C7E99 Q36963380-2043FDAB-67B9-49C0-B9E4-2A95DB31597C Q37003623-E2663A25-FA65-489F-A3A8-6F19405CF5F3 Q37056383-19B0B29D-3818-47BC-85DA-AAFE4F545594 Q37227466-621AF988-5EFC-4B04-A713-B6F1DC51C449

P2860

Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1

http://www.wikidata.org/entity/Q35060239

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Restriction of advanced glycat ...... ential role of AGER1 and SIRT1

@ast

Restriction of advanced glycat ...... ential role of AGER1 and SIRT1

@en

type

label

Restriction of advanced glycat ...... ential role of AGER1 and SIRT1

@ast

Restriction of advanced glycat ...... ential role of AGER1 and SIRT1

@en

prefLabel

Restriction of advanced glycat ...... ential role of AGER1 and SIRT1

@ast

Restriction of advanced glycat ...... ential role of AGER1 and SIRT1

@en

P1433

Q35060239-837BCD29-119F-4B58-BE7B-1A9670180F38

P1476

Q35060239-934F553E-4159-4714-846E-019ED3AA6009

P2093

Q35060239-2DFD3634-A906-422D-89CB-19DB331925E5

Q35060239-44E2AD40-3E72-4C03-921A-FCE513A4F28E

Q35060239-84E32816-1C60-4AB7-ACA5-95D0E957FF52

Q35060239-910C2D64-8A09-4C42-9911-C55225944CD3

Q35060239-B72CABFD-58F6-46C8-A31A-935BACEB3A90

Q35060239-C070A18A-0E99-4297-9F33-06C3BFD170DE

Q35060239-D7110323-352F-44CE-8932-4B39B4713C37

Q35060239-E7254F0C-596E-4CB5-AD32-F73E7FE74344

Q35060239-ED3B740E-3475-4EDD-9047-AE4AC10290C5

P2860

Q35060239-0320ED80-9BBB-434E-AA3E-745A876451CA

Q35060239-03DE17DF-6F4E-4BB9-9C92-6A8FF1EE5025

Q35060239-0725E874-4554-48C5-91C9-E170B6D74022

Q35060239-2AA9444A-85AA-44D7-BFF0-02F8BAC70DF7

Q35060239-2BF3A42D-8958-4309-9E85-3C82AA9D6F2A

Q35060239-3415EFED-6093-431C-B1E5-85F8299E7D9C

Q35060239-36E1BF6A-9543-4746-B20A-E646C517B5C3

Q35060239-577F78BD-A007-4093-AE15-06D6A0676D8C

Q35060239-58BB6BCA-65FA-4AB7-A54E-688C0F17DFC9

Q35060239-66C2C227-3C6B-4541-950C-7E42597246EF

P304

Q35060239-EF9D4604-A4E7-4F6A-979A-1CB73965CA7C

P31

Q35060239-55671146-24B4-4F58-ADEE-12558460A674

P356

Q35060239-2A86B2DD-EDAF-4C58-9C4E-8B074589F023

P407

Q35060239-62816061-3993-4D0D-B59C-FED16E596B28

P433

Q35060239-FF7AE744-916A-4E4B-B9AC-7C6D8AA7F111

P478

Q35060239-9376B6E7-589A-4F6B-8C96-3ABABA628CD1

P577

Q35060239-91C1713C-3DA8-4584-8E47-794D9419E241

P5875

Q35060239-F2B719CB-EFCA-4319-8856-87F9C8C36042

P698

Q35060239-0EB13E0F-5A1C-41A1-9587-CD42A76EEAEB

P921

Q35060239-6C9EB412-52F9-48A8-92A0-B6357CE6D73C

Q35060239-F8742478-59B1-440B-B64F-8838F66B685E

P932

Q35060239-63F1354E-1127-4281-A2E1-D5F58C03A3F4

P356

P1433

P1476

Restriction of advanced glycat ...... ential role of AGER1 and SIRT1

@en

P2093

Gary E Striker

http://www.w3.org/2001/XMLSchema#string

Helen Vlassara

http://www.w3.org/2001/XMLSchema#string

Jaime Uribarri

http://www.w3.org/2001/XMLSchema#string

Li Zhu

http://www.w3.org/2001/XMLSchema#string

Maya Ramdas

http://www.w3.org/2001/XMLSchema#string

Renata Pyzik

http://www.w3.org/2001/XMLSchema#string

Susan Goodman

http://www.w3.org/2001/XMLSchema#string

Weijing Cai

http://www.w3.org/2001/XMLSchema#string

Xue Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and insulin resistance

Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk

Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells

Advanced glycation end products in foods and a practical guide to their reduction in the diet

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE

SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex

Macrophages, inflammation, and insulin resistance

Mammalian sirtuins: biological insights and disease relevance

Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms

P304

1610-1616

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC11-0091

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51253765

http://www.w3.org/2001/XMLSchema#string

P698

21709297

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3120204

http://www.w3.org/2001/XMLSchema#string